Dynavax Technologies
DVAX
#5527
Rank
โ‚ฌ1.08 B
Marketcap
9,20ย โ‚ฌ
Share price
-0.55%
Change (1 day)
-25.39%
Change (1 year)

Market capitalization of Dynavax Technologies (DVAX)

Market cap: โ‚ฌ1.08 Billion

As of December 2025 Dynavax Technologies has a market cap of โ‚ฌ1.08 Billion. This makes Dynavax Technologies the world's 5527th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Dynavax Technologies from 2004 to 2025

End of year Market Cap

Year Marketcap Change
2025โ‚ฌ1.08 B-34.22%
2024โ‚ฌ1.64 B0.46%
2023โ‚ฌ1.63 B29.17%
2022โ‚ฌ1.26 B-15.08%
2021โ‚ฌ1.49 B273.82%
2020โ‚ฌ0.39 B-6.91%
2019โ‚ฌ0.42 B-14.82%
2018โ‚ฌ0.50 B-46.76%
2017โ‚ฌ0.94 B552.75%
2016โ‚ฌ0.14 B-82.97%
2015โ‚ฌ0.84 B132.94%
2014โ‚ฌ0.36 B-2.22%
2013โ‚ฌ0.37 B-5.3%
2012โ‚ฌ0.39 B21.49%
2011โ‚ฌ0.32 B16.56%
2010โ‚ฌ0.27 B417%
2009โ‚ฌ53.79 M124.66%
2008โ‚ฌ23.94 M-82.79%
2007โ‚ฌ0.13 B-49.63%
2006โ‚ฌ0.27 B228.41%
2005โ‚ฌ84.13 M-39.74%
2004โ‚ฌ0.13 B

End of Day market cap according to different sources

On Dec 13th, 2025 the market cap of Dynavax Technologies was reported to be:

โ‚ฌ1.08 Billion
by Nasdaq info icon info icon
โ‚ฌ1.08 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Agenus
AGEN
โ‚ฌ0.10 B-89.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
โ‚ฌ21.75 B 1,913.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚ฌ213.40 B 19,654.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
โ‚ฌ127.25 B 11,680.03%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚ฌ237.25 B 21,862.32%๐Ÿ‡ฌ๐Ÿ‡ง UK
GlaxoSmithKline
GSK
โ‚ฌ83.89 B 7,666.34%๐Ÿ‡ฌ๐Ÿ‡ง UK
Pfizer
PFE
โ‚ฌ125.19 B 11,489.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
โ‚ฌ29.11 B 2,594.99%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Amgen
AMGN
โ‚ฌ145.74 B 13,391.42%๐Ÿ‡บ๐Ÿ‡ธ USA